To: Board of Supervisors
From: Dr. Grant Colfax, Health Services Director
Report Title: Contract # 76-761-5 with Bureau Veritas North America, Inc.
☒Recommendation of the County Administrator ☐ Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Health Services Director, or designee, to execute on behalf of the County, Contract #76-761-5 with Bureau Veritas North America, Inc, a corporation, in an amount not to exceed $70,000, to provide chemotherapy surface contamination testing services for the Contra Costa Regional Medical Center (CCRMC) Chemotherapy Infusion Pharmacy, for the period November 1, 2025 through October 31, 2026.
FISCAL IMPACT:
This Contract will result in contractual service expenditures of up to $70,000 over a 2-year period and will be funded 100% by Hospital Enterprise Fund I revenues.
BACKGROUND:
The County has an obligation to provide certain specialized surface contamination testing support services for the CCRMC Chemotherapy Infusion Pharmacy. These test samples are sent to the Contractor to be tested for possible chemotherapy contamination on CCRMC pharmacy surfaces. This Contractor has been providing these contamination testing services for the County and fostering a deep understanding of the CCRMC organization’s mission, values, and long-term objectives since November 1, 2021. This Contract is entered into under and subject to the following legal authorities: California Government Code §§ 26227 and 31000; Health and Safety Code § 1451. The California State Board of Pharmacy and US Pharmacopeia (USP) 787 and 800 laws require testing of all surfaces that encounter hazardous drugs to ensure employee and patient safety. Health Services Personnel approved this Contract to ensure no conflicts with labor relations.
Contractor currently cooperates with and participates in CCRMC’s Quality Assurance Program which consists of quality improvement activities such as assisting with the completion of CCRMC’s annual performance review. Contractor has a demonstrated history of maintaining the required accreditations and compliance with these federal regulations. This contractor was approved by the Public Works Department’s Purchasing Division on August 4, 2025.
On November 12, 2024, the Board of Supervisors approved Contract #76-761-4 with Bureau Veritas North America, Inc., in an amount not to exceed $70,000, to provide chemotherapy surface contamination testing services for the CCRMC’s Chemotherapy Infusion Pharmacy for the period November 1, 2024 through October 31, 2025.
Approval of this Contract #76-761-5 will allow the Contractor to continue to provide chemotherapy surface contamination testing services at the CCRMC Chemotherapy Infusion Pharmacy through October 31, 2026. This Contract limits the County and Contractor’s liability so that each party shall contribute the amount of its proportionate share. Neither party shall be liable for certain damages, including indirect or consequential, exemplary, punitive, or special damages. This Contract also modifies the County’s standard indemnification provision. This Contract delay was due to extended negotiations between Contractor and Division.
CONSEQUENCE OF NEGATIVE ACTION:
If this Contract is not approved, certain specialized chemotherapy surface contamination testing services for CCRMC will not be provided and may risk County being out of compliance with the California State Board of Pharmacy.